Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C4H4O6.2Na |
Molecular Weight | 194.0505 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Na+].O[C@H]([C@@H](O)C([O-])=O)C([O-])=O
InChI
InChIKey=HELHAJAZNSDZJO-OLXYHTOASA-L
InChI=1S/C4H6O6.2Na/c5-1(3(7)8)2(6)4(9)10;;/h1-2,5-6H,(H,7,8)(H,9,10);;/q;2*+1/p-2/t1-,2-;;/m1../s1
Molecular Formula | Na |
Molecular Weight | 22.9898 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C4H4O6 |
Molecular Weight | 148.071 |
Charge | -2 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Tartaric acid is found in many plants such as grapes, tamarinds, pineapples, mulberries and so on. Wine lees (called mud in the US), the sediment collected during the fermentation of grapes, contains potassium bitartrate (potassium hydrogen tartrate) as its major component. L-(+)-tartaric acid is an enantiomer of tartaric acid. Twenty five years before the tetrahedral structure for carbon was proposed in 1874 to explain the optical activity and other properties of organic compounds, Louis Pasteur discovered the existence of enantiomerism in tartaric acid. L-(+)-tartaric acid is widely used in food and beverage as acidity regulator with E number E334.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Synthesis and evaluation of a C-glycosyl nucleoside as an inhibitor of chitin synthase. | 2001 Aug 30 |
|
Production and chemiluminescent free radical reactions of glyoxal in lipid peroxidation of linoleic acid by the ligninolytic enzyme, manganese peroxidase. | 2001 Dec |
|
A comparison of salts for the crystallization of macromolecules. | 2001 Feb |
|
Sarcosinium tartrate. | 2001 Feb |
|
Reversal of multidrug resistance-associated protein-mediated drug resistance in cultured human neuroblastoma cells by the quinolone antibiotic difloxacin. | 2001 Jan |
|
Comparison of the clinical success and quality-of-life impact of brimonidine 0.2% and betaxolol 0.25 % suspension in patients with elevated intraocular pressure. | 2001 Jul |
|
Malo-ethanolic fermentation in grape must by recombinant strains of Saccharomyces cerevisiae. | 2001 Jul |
|
Isolation and characterization of Mn(III) tartrate from Phanerochaete chrysosporium culture broth. | 2001 Jul 24 |
|
Determination of organic acids of low molecular weight and phosphate in soil by capillary electrophoresis. | 2001 Jul-Aug |
|
Catalytic spectrophotometric determination of vanadium in seawaters based on the bromate oxidative coupling reaction of metol and 2,3,4-trihydroxybenzoic acid. | 2001 Jun |
|
Chiral separations of transition metal complexes using capillary zone electrophoresis. | 2001 Jun 15 |
|
Mutation of a single conserved tryptophan in multidrug resistance protein 1 (MRP1/ABCC1) results in loss of drug resistance and selective loss of organic anion transport. | 2001 May 11 |
|
[Acid phosphatase, ACP (EC 3.1.3.2)]. | 2001 Nov |
|
Technetium-99m direct radiolabeling of lanreotide: a somatostatin analog. | 2001 Nov |
|
Novel bicistronic retroviral vector expressing gamma-glutamylcysteine synthetase and the multidrug resistance protein 1 (MRP1) protects cells from MRP1-effluxed drugs and alkylating agents. | 2001 Sep 20 |
|
Preformulation studies for an ultrashort-acting neuromuscular blocking agent GW280430A. I. Buffer and cosolvent effects on the solution stability. | 2002 |
|
The MRP1-mediated effluxes of arsenic and antimony do not require arsenic-glutathione and antimony-glutathione complex formation. | 2002 Apr |
|
The structure and mechanism of the type II dehydroquinase from Streptomyces coelicolor. | 2002 Apr |
|
Stereoselective synthesis of myo-inositol via ring-closing metathesis: a building block for glycosylphosphatidylinositol (GPI) anchor synthesis. | 2002 Apr 18 |
|
Towards atomic resolution with crystals grown in gel: the case of thaumatin seen at room temperature. | 2002 Aug 1 |
|
Thermophysical properties of pharmaceutically compatible buffers at sub-zero temperatures: implications for freeze-drying. | 2002 Feb |
|
Ergotamine-induced anorectal strictures: report of five cases. | 2002 Feb |
|
Revision of absolute configuration of enantiomeric (methylenecyclopropyl)carbinols obtained from (R)-(-)- and (S)-(+)-epichlorohydrin and methylenetriphenylphosphorane. Implications for reaction mechanism and improved synthesis of antiviral methylenecyclopropane analogues of nucleosides. | 2002 Jan 11 |
|
Effect of antibiotics on in vitro and in vivo avian cartilage degradation. | 2002 Jan-Mar |
|
Improving the labeling of S-acetyl NHS-MAG(3)-conjugated morpholino oligomers. | 2002 Jul-Aug |
|
Dissociation of angiogenesis and osteoclastogenesis during endochondral bone formation in neonatal mice. | 2002 Jun |
|
Consumption of an omega-3 fatty acids product, INCELL AAFA, reduced side-effects of CPT-11 (irinotecan) in mice. | 2002 Mar 18 |
|
Potassium antimonyl tartrate induces reactive oxygen species-related apoptosis in human myeloid leukemic HL60 cells. | 2002 May |
|
Formation of methylantimony species by an aerobic prokaryote: Flavobacterium sp. | 2002 Oct |
|
Development of high-affinity ligands and photoaffinity labels for the D-fructose transporter GLUT5. | 2002 Oct 15 |
|
Symmetric and helical growth of polyacetylene fibers over a single copper crystal derived from copper tartrate decomposition. | 2002 Sep 5 |
Sample Use Guides
L-(+)-tartaric acid as a food additive. Acceptable Daily Intake: 0-30 mg/kg
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3540104
After incubation in medium containing 50 mM L(+)-tartaric acid, osteoclasts and chondroclasts were heavily stained with reaction product.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:10:24 GMT 2023
by
admin
on
Fri Dec 15 15:10:24 GMT 2023
|
Record UNII |
QTO9JB4MDD
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
JECFA EVALUATION |
INS-335(II)
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
||
|
CFR |
21 CFR 184.1801
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
||
|
CFR |
21 CFR 331.11
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
||
|
WHO-VATC |
QA06AD21
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
||
|
WHO-ATC |
A06AD21
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
||
|
CFR |
21 CFR 331.15
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
||
|
CODEX ALIMENTARIUS (GSFA) |
INS-335(II)
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m10082
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
PRIMARY | Merck Index | ||
|
56524
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
PRIMARY | RxNorm | ||
|
DB13707
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
PRIMARY | |||
|
DTXSID2057861
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
PRIMARY | |||
|
QTO9JB4MDD
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
PRIMARY | |||
|
SUB15327MIG
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
PRIMARY | |||
|
100000078124
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
PRIMARY | |||
|
SODIUM TARTRATE
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
PRIMARY | |||
|
C45678
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
CONCEPT | Industrial Aid | ||
|
4780
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
PRIMARY | |||
|
162637
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107781
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
PRIMARY | |||
|
868-18-8
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
PRIMARY | |||
|
C029768
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
PRIMARY | |||
|
C77502
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
PRIMARY | |||
|
63017
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
PRIMARY | |||
|
QTO9JB4MDD
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
PRIMARY | |||
|
212-773-3
Created by
admin on Fri Dec 15 15:10:25 GMT 2023 , Edited by admin on Fri Dec 15 15:10:25 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SOLVATE->ANHYDROUS | |||
|
PARENT -> SALT/SOLVATE |